Forte Biosciences (FBRX) News Today $10.18 -0.12 (-1.12%) As of 01:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Forte Biosciences (FBRX) to Release Earnings on WednesdayAugust 7 at 6:18 AM | marketbeat.comForte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX)August 7 at 2:47 AM | marketbeat.comForte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)July 24, 2025 | marketbeat.comForte Biosciences Prices $75 Mln Public Offering Of Common Stock And Pre-Funded Warrants - NasdaqJune 27, 2025 | nasdaq.comForte Biosciences Announces Pricing of $75 Million Public Offering - Business WireJune 26, 2025 | businesswire.comForte Biosciences Inc News (FBRX) - Investing.comJune 26, 2025 | investing.comForte Biosciences stock falls after pricing capital raise of $75M via securities offeringJune 25, 2025 | msn.comForte Biosciences Announces Pricing of $75 Million Public OfferingJune 24, 2025 | businesswire.comForte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study - MorningstarJune 24, 2025 | morningstar.comMForte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study - NasdaqJune 24, 2025 | nasdaq.comForte Biosciences announces data from trial in celiac disease for FB102June 24, 2025 | finance.yahoo.comForte Biosciences Shares Fall After Proposed Public OfferingJune 24, 2025 | marketwatch.comForte Biosciences launches public offeringJune 24, 2025 | msn.comForte Biosciences Announces Proposed Public OfferingJune 24, 2025 | businesswire.comForte Biosciences (NASDAQ:FBRX) Earns Buy Rating from Chardan CapitalJune 24, 2025 | marketbeat.comForte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B StudyJune 23, 2025 | businesswire.comForte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Up 33.5% in MayJune 17, 2025 | marketbeat.comTraders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)June 12, 2025 | marketbeat.comShort Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Increases By 18.5%June 5, 2025 | marketbeat.comForte Biosciences Stock Price, Quotes and Forecasts | NASDAQ:FBRX | BenzingaJune 1, 2025 | benzinga.comWoodline Partners LP Takes Position in Forte Biosciences, Inc. (NASDAQ:FBRX)May 26, 2025 | marketbeat.comTybourne Capital Management HK Ltd. Raises Stake in Forte Biosciences, Inc. (NASDAQ:FBRX)May 21, 2025 | marketbeat.comTD Cowen Remains a Buy on Forte Biosciences (FBRX)May 17, 2025 | theglobeandmail.comForte Biosciences price target lowered to $61 from $64 at ChardanApril 2, 2025 | markets.businessinsider.comIs Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?April 1, 2025 | finance.yahoo.comForte Biosciences (FBRX) Gets a Buy from TD CowenApril 1, 2025 | markets.businessinsider.comForte Biosciences, Inc. Announces Results and Provides Clinical UpdateMarch 31, 2025 | finance.yahoo.comForte Biosciences files $300M mixed securities shelfMarch 28, 2025 | markets.businessinsider.comForte Biosciences, Inc. (NASDAQ:FBRX) Short Interest UpdateFebruary 28, 2025 | marketbeat.comForte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX)February 20, 2025 | marketbeat.comOne Forte Biosciences Insider Raised Stake By 273% In Previous YearFebruary 19, 2025 | finance.yahoo.comForte Biosciences, Inc. to Present at Upcoming Investor MeetingsFebruary 3, 2025 | finance.yahoo.comTD Cowen Initiates Coverage of Forte Biosciences (FBRX) with Buy RecommendationJanuary 22, 2025 | msn.comForte Biosciences initiated with a Buy at TD CowenJanuary 21, 2025 | markets.businessinsider.comTD Cowen initiates Forte Biosciences stock with Buy ratingJanuary 21, 2025 | msn.comAntony A. Riley Purchases 22,514 Shares of Forte Biosciences, Inc. (NASDAQ:FBRX) StockNovember 23, 2024 | insidertrades.comForte Biosciences (NASDAQ:FBRX) Stock, Short Interest ReportNovember 22, 2024 | benzinga.comForte Biosciences More Than Doubles on $53M Private PlacementNovember 21, 2024 | marketwatch.comForte Biosciences trading halted, volatility trading pauseNovember 21, 2024 | markets.businessinsider.comForte Biosciences Secures $53M for FB102 AdvancementsNovember 21, 2024 | markets.businessinsider.comForte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes WildNovember 21, 2024 | msn.comForte Biosciences Inc. Reports Q3 2024 EarningsNovember 15, 2024 | markets.businessinsider.comForte Biosciences, Inc. (NASDAQ:FBRX) Sees Significant Growth in Short InterestAugust 28, 2024 | marketbeat.comForte Biosciences Inc (37TA.MU)August 28, 2024 | au.finance.yahoo.com37TA.SG,0P0001K59E,0 (37TA.SG)August 28, 2024 | au.finance.yahoo.comForte Biosciences Inc (37TA.BE)August 28, 2024 | nz.finance.yahoo.comForte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business UpdateAugust 15, 2024 | businesswire.comIs Forte Biosciences, Inc. (FBRX) One of the Best Penny Stocks to Buy Now Under $1?July 15, 2024 | insidermonkey.comCompanies Like Forte Biosciences (NASDAQ:FBRX) Could Be Quite RiskyMay 21, 2024 | finance.yahoo.comForte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing RulesMay 17, 2024 | businesswire.com Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address FBRX Media Mentions By Week FBRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBRX News Sentiment▼0.450.37▲Average Medical News Sentiment FBRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBRX Articles This Week▼30▲FBRX Articles Average Week Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SGMT News Today IMMP News Today NMRA News Today ACB News Today ZYBT News Today MNPR News Today DBVT News Today TVRD News Today DRUG News Today ALLO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBRX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
